Report Description

India carbamazepine market is expected to grow at a steady rate during the forecast period. The India carbamazepine market is driven by use of these drugs for the treatment of epilepsy and neuropathic pain. Carbamazepine are available as chewable tablet, suspension, tablet, extended release tablet, and extended release capsule. In addition to this, upsurge in the demand for carbamazepine for treating numerous types of seizures and bipolar disorders is expected to rev up the market growth through FY2026. Additionally, supportive government policies and improving healthcare infrastructure are some other reasons that are expected to create lucrative opportunities for the market growth over the next few years.


The India carbamazepine market is segmented based on route of administration, source, form, distribution channel, application, end user, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. Out of which, the in-house segment dominated the market until 2017 owing to in house production preference by the major market players. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period on account of increased outsourcing activities by the major companies in order to focus on their R&D activity and expansion plans. Additionally, contract manufacturing organizations offer competitive pricing and can provide bulk orders in lesser duration.


The major players operating in the India carbamazepine market are Taj Pharmaceuticals Ltd, Jubilant Pharma Ltd., Novartis India Ltd., Abbott India Ltd., Psychotropics India Limited, Anuja Healthcare Limited, Taro Pharmaceuticals India Pvt. Ltd., Teva Pharmaceuticals Industries Ltd., Biomed Pharmaceuticals Pvt. Ltd., Sun Pharmaceuticals Industries Limited and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include product launches, mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India carbamazepine market from FY2016 to FY2019.
  • To estimate and forecast the market size of India carbamazepine market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India carbamazepine market based on route of administration, source, form, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India carbamazepine market.
  • To identify drivers and challenges for India carbamazepine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India carbamazepine market.
  • To identify and analyze the profile of leading players operating in India carbamazepine market.
  • To identify key sustainable strategies adopted by market players in India carbamazepine market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India carbamazepine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Carbamazepine manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to carbamazepine

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India carbamazepine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Carbamazepine Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Carbamazepine Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Carbamazepine Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Syrup
    • Others
  • India Carbamazepine Market, By Distribution Channel:
    • Online
    • Offline
  • India Carbamazepine Market, By Application:
    • Epilepsy
    • Neuropathic Pain
    • Seizure
    • Bipolar Disorder
    • Trigeminal Neuralgia
    • Others
  • India Carbamazepine Market, By End User:
    • Adult
    • Paediatric
  • India Carbamazepine Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India carbamazepine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India carbamazepine market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Carbamazepine Market

4.    Executive Summary

5.    Manufacturing Carbamazepine

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Carbamazepine

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Carbamazepine Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Route of Administration (Oral v/s Intravenous)

7.2.2.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.3.     By Form (Tablet, Capsule, Injection, Syrup, Others)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Application (Epilepsy, Neuropathic Pain, Seizure, Bipolar Disorder, Trigeminal Neuralgia, Others)

7.2.6.     By End User (Adult v/s Paediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Taj Pharmaceuticals Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Jubilant Pharma Ltd.

14.1.3.  Novartis India Ltd.

14.1.4.  Abbott India Ltd.

14.1.5.  Psychotropics India Limited

14.1.6.  Anuja Healthcare Limited

14.1.7.  Taro Pharmaceuticals India Pvt. Ltd.

14.1.8.  Teva Pharmaceuticals Industries Ltd.

14.1.9.  Biomed Pharmaceuticals Pvt. Ltd.

14.1.10.                Sun Pharmaceuticals Industries Limited

15.  Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions






Sakshi Bajaal

Business Consultant
Press Release

India Carbamazepine Market to grow at a steady rate During the Forecast Period

Nov, 2020

Growing cases of epilepsy in the country is expected to drive the growth of India Carbamazepine market during the forecast period.